Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
USNA Stock Forecast 2025-2026
$20.87
Current Price
$381.52M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to USNA Price Targets
+86.9%
To High Target of $39.00
+86.9%
To Median Target of $39.00
+86.9%
To Low Target of $39.00
USNA Price Momentum
+6.4%
1 Week Change
+9.8%
1 Month Change
-44.7%
1 Year Change
-41.9%
Year-to-Date Change
-46.3%
From 52W High of $38.85
+12.9%
From 52W Low of $18.48
📊 TOP ANALYST CALLS
Did USNA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if USANA is one of their latest high-conviction picks.
Latest USNA Stock Price Targets & Analyst Predictions
USNA has shown a year-to-date change of -41.9% and a 1-year change of -44.7%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for USNA. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
USNA Analyst Ratings
0
Buy
0
Hold
0
Sell
USNA Price Target Range
Low
$39.00
Average
$39.00
High
$39.00
Current: $20.87
Latest USNA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for USNA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 27, 2025 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $36.00 |
| Jan 2, 2025 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $38.00 |
| Oct 23, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $35.00 |
| Jul 25, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $38.00 |
| May 7, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $46.00 |
| Feb 22, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $48.00 |
| Oct 25, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $53.00 |
| Apr 26, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $56.00 |
| Feb 13, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $52.50 |
| Oct 27, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $49.00 |
| Jul 28, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $57.00 |
| Jul 12, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $58.00 |
| Jul 7, 2022 | Jefferies | Stephanie Wissink | Underperform | Downgrade | $53.00 |
| Apr 27, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $76.00 |
| Apr 14, 2022 | DA Davidson | Neutral | Initiates | $N/A | |
| Feb 10, 2021 | Roth Capital | David Bain | Buy | Maintains | $126.00 |
| Dec 17, 2020 | Roth Capital | Buy | Initiates | $N/A | |
| Aug 22, 2019 | Jefferies | Hold | Initiates | $N/A | |
| Jul 3, 2019 | Sidoti & Co. | Neutral | Downgrade | $70.00 | |
| Apr 16, 2019 | Tigress Financial | Buy | Initiates | $N/A |
Usana Health Sciences, Inc. (USNA) Competitors
The following stocks are similar to USANA based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Usana Health Sciences, Inc. (USNA) Financial Data
Usana Health Sciences, Inc. has a market capitalization of $381.52M with a P/E ratio of 21.6x. The company generates $912.67M in trailing twelve-month revenue with a 1.9% profit margin.
Revenue growth is +6.7% quarter-over-quarter, while maintaining an operating margin of +0.6% and return on equity of +3.2%.
Valuation Metrics
Market Cap
$381.52M
Enterprise Value
$271.37M
P/E Ratio
21.6x
PEG Ratio
-0.1x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
+6.7%
Gross Margin
+77.2%
Operating Margin
+0.6%
Net Margin
+1.9%
EPS Growth
+6.7%
Financial Health
Cash/Price Ratio
+38.1%
Current Ratio
2.2x
Debt/Equity
0.0x
ROE
+3.2%
ROA
+3.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Usana Health Sciences, Inc. (USNA) Business Model
About Usana Health Sciences, Inc.
What They Do
Develops and distributes nutritional supplements and personal care products.
Business Model
Usana operates on a direct selling model, allowing independent entrepreneurs to sell its high-quality vitamins, dietary supplements, and personal care items. This business model not only boosts product sales but also creates opportunities for individuals to start their own businesses and earn income while promoting health and wellness.
Additional Information
Founded in 1992, Usana prioritizes scientific research and innovation, ensuring the efficacy and safety of its products. The company has established a strong reputation among health-conscious consumers and medical professionals, positioning itself effectively in the growing global health and wellness market.
Company Information
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
1,700
CEO
Mr. Jim Brown
Country
United States
IPO Year
1995
Website
www.usana.comUsana Health Sciences, Inc. (USNA) Latest News & Analysis
Latest News
Quick Summary
National Make a Gift Day on December 3 promotes generosity and personal connections through meaningful gift-making, highlighting consumer engagement opportunities for businesses.
Why It Matters
Consumer sentiment around gifting can boost retail sales, impacting earnings for companies in the consumer goods sector. Positive trends may signal growth opportunities for investors.
Source: PRNewsWire
Market Sentiment:
Neutral
Proven Power for Strong Bone Support--USANA's MagneCal D Earns ConsumerLab.com Seal of Approval
1 month ago
Quick Summary
USANA's MagneCal D supplement has received the ConsumerLab.com Seal of Approval for purity and potency, highlighting its importance for bone health amid rising consumer demand.
Why It Matters
USANA's MagneCal D earning ConsumerLab.com approval boosts its credibility, likely increasing sales and market share in a growing health supplement sector, positively impacting stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
On November 5, 2025, the USANA Foundation and partners assembled 3,000 food bags to combat rising food insecurity among Utah families, responding to recent federal SNAP cuts.
Why It Matters
Rising food insecurity may indicate economic stress, affecting consumer spending and business performance. Companies involved in community support could enhance brand loyalty and mitigate reputational risks.
Source: PRNewsWire
Market Sentiment:
Neutral
USANA Executive Chairman Kevin Guest Calls for a "Great Re-Engagement" Rooted in Trust, Empathy, Purpose
1 month ago
Quick Summary
USANA Health Sciences' Executive Chairman Kevin Guest emphasizes the importance of authenticity, empathy, and moral clarity for sustainable success in leadership amid workforce revitalization efforts.
Why It Matters
Kevin Guest's emphasis on authenticity and empathy signals a shift in corporate leadership trends, potentially affecting USANA's performance and investor sentiment regarding sustainable business practices.
Source: PRNewsWire
Market Sentiment:
Neutral
Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600
1 month ago
Quick Summary
Effective October 31, Solstice Advance Materials Inc. will replace CarMax Inc. in the S&P 500, while CarMax will take USANA Health Sciences' spot in the S&P SmallCap 600.
Why It Matters
Changes in index composition can impact stock prices and investor sentiment. The addition of Solstice Advance Materials to the S&P 500 may attract more institutional investment, influencing overall market dynamics.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
USANA Health Sciences, Inc. will hold its Q3 2025 earnings call on October 23, 2025, at 11:00 AM EDT, featuring key executives including CEO Jim Brown and CFO G. Hekking.
Why It Matters
The earnings call offers insights into USANA's financial performance and strategic direction, crucial for assessing its investment potential and market competitiveness.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About USNA Stock
What is Usana Health Sciences, Inc.'s (USNA) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, Usana Health Sciences, Inc. (USNA) has a median price target of $39.00. The highest price target is $39.00 and the lowest is $39.00.
Is USNA stock a good investment in 2026?
Analyst ratings for USNA are not currently available. The stock is currently trading at $20.87. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for USNA stock?
Wall Street analysts predict USNA stock could reach $39.00 in the next 12 months. This represents a 86.9% increase from the current price of $20.87. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Usana Health Sciences, Inc.'s business model?
Usana operates on a direct selling model, allowing independent entrepreneurs to sell its high-quality vitamins, dietary supplements, and personal care items. This business model not only boosts product sales but also creates opportunities for individuals to start their own businesses and earn income while promoting health and wellness.
What is the highest forecasted price for USNA Usana Health Sciences, Inc.?
The highest price target for USNA is $39.00 from at , which represents a 86.9% increase from the current price of $20.87.
What is the lowest forecasted price for USNA Usana Health Sciences, Inc.?
The lowest price target for USNA is $39.00 from at , which represents a 86.9% increase from the current price of $20.87.
What is the overall USNA consensus from analysts for Usana Health Sciences, Inc.?
Analyst ratings for USNA are not currently available. The stock is trading at $20.87.
How accurate are USNA stock price projections?
Stock price projections, including those for Usana Health Sciences, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 11, 2025 4:38 AM UTC